Insider Sellers Might Regret Selling Organogenesis Holdings Shares at a Lower Price Than Current Market Value
Organogenesis Holdings Inc.'s (NASDAQ:ORGO) stock price has dropped 20% in the previous week, but insiders who sold US$941k in stock over the past year have had less luck. Given that the average sell
Simply Wall StApr 26 08:24 ET
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Caterpillar Inc. (NYSE:CAT) fell sharply during Thursday's session after the company reported better-than-expected first-quarter EPS but missed revenue estimates.Caterpillar reported a first
BenzingaApr 25 13:57 ET
12 Health Care Stocks Moving In Thursday's Intraday Session
GainersAclarion (NASDAQ:ACON) shares moved upwards by 66.7% to $0.48 during Thursday's regular session. The market value of their outstanding shares is at $3.4 million. Processa Pharma (NASDAQ:PCSA) s
BenzingaApr 25 12:31 ET
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024
CANTON, Mass., April 16, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (NASDAQ:ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions
GlobeNewswireApr 16 07:30 ET
Express News | Organogenesis Announced Favorable Ruling From United States District Court Dismissing Securities Fraud Case
Moomoo 24/7Apr 3 07:33 ET
Organogenesis Announces Favorable Court Ruling Dismissing Securities Fraud Case
CANTON, Mass., April 03, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (NASDAQ:ORGO) a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions
GlobeNewswireApr 3 07:30 ET
Earnings Call Summary | Organogenesis(ORGO.US) Q4 2023 Earnings Conference
The following is a summary of the Organogenesis Holdings, Inc. (ORGO) Q4 2023 Earnings Call Transcript:Financial Performance:Organogenesis reported Q4 net revenue of $99.7 million, a decrease of 14% y
moomoo AIMar 20 09:31 ET · Conference Call
Buy Rating Affirmed for Organogenesis Holdings Amid Stable Product Pricing and Positive Market Dynamics
TipRanksMar 19 06:19 ET
Organogenesis Holdings Inc.'s (NASDAQ:ORGO) P/E Is On The Mark
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 16x, you may consider Organogenesis Holdings Inc. (NASDAQ:ORGO) as a stock to avoid entirely with
Simply Wall StMar 4 08:55 ET
Organogenesis Holdings Full Year 2023 Earnings: Misses Expectations
Yahoo FinanceMar 2 09:39 ET
Organogenesis Holdings Inc. (NASDAQ:ORGO) Q4 2023 Earnings Call Transcript
Yahoo FinanceMar 2 08:39 ET
Why Organogenesis Holding Stock Plummeted by 18% Today
The Motley FoolMar 1 18:29 ET
Express News | Cantor Fitzgerald Reiterates Overweight on Organogenesis Hldgs, Maintains $5 Price Target
Moomoo 24/7Mar 1 09:35 ET
Organogenesis Holdings: A Buy Rating With Anticipated Turnaround and Growth Prospects
TipRanksMar 1 06:58 ET
Organogenesis (ORGO) Q4 2023 Earnings Call Transcript
Yahoo FinanceFeb 29 21:00 ET
Express News | Organogenesis Holdings Sees FY24 Revenue $445M-$470M Vs $455.949M Est
Moomoo 24/7Feb 29 16:38 ET
Recap: Organogenesis Hldgs Q4 Earnings
Organogenesis Hldgs (NASDAQ:ORGO) reported its Q4 earnings results on Thursday, February 29, 2024 at 04:05 PM.Here's what investors need to know about the announcement.EarningsOrganogenesis Hldgs miss
BenzingaFeb 29 16:15 ET
Express News | Organogenesis Hldgs Q4 2023 GAAP EPS $0.010, Inline, Sales $99.651M Miss $109.050M Estimate
Moomoo 24/7Feb 29 16:13 ET
Organogenesis Holdings 4Q Loss $568,000 >ORGO
Organogenesis Holdings 4Q Loss $568,000 >ORGO
Dow JonesFeb 29 16:05 ET
Press Release: Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance
Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance CANTON, Mass., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Organogenesis Hol
Dow JonesFeb 29 16:05 ET
No Data
No Data